Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA EN NL april 29, 2022
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following EUR > 10 million Private Placement and conversion notice from NEGMA EN NL maart 30, 2022
Nieuws Regulated Transparency/Denominator Oxurion Receives Transparency Notifications from Fidelity Management & Research Company LLC and Novartis Pharma AG EN NL maart 17, 2022
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following conversion notices from NEGMA EN NL februari 22, 2022
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following conversion notices from NEGMA EN NL december 30, 2021
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following conversion notices from NEGMA EN NL november 30, 2021
Nieuws Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following conversion notices NEGMA EN NL november 3, 2021
Nieuws Regulated Transparency/Denominator Regulated information – Transparency Statement OXUR shares EN NL mei 10, 2019
Nieuws Regulated Transparency/Denominator Regulated information – Transparency Statement Clay EN NL mei 10, 2019
Nieuws Regulated Transparency/Denominator Regulated Information / Transparency Statement EN NL april 27, 2018
Nieuws Regulated Transparency/Denominator NOVARTIS PHARMA AG HOLDING 5.69% OF THROMBOGENICS EQUITY CAPITAL EN NL januari 26, 2018
